SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors.
Biomolecules. 2021 Apr 19;11(4):607. doi: 10.3390/biom11040607.
Biomolecules. 2021.
PMID: 33921886
Free PMC article.
Review.